Abstract
The regulation of T cell-mediated immune responses requires a balance between amplification and generation of effector function and subsequent selective termination by clonal deletion. Although apoptosis of previously activated T cells can be induced by signaling of the tumor necrosis factor receptor family, these molecules do not appear to regulate T-cell clonal deletion in an antigen-specific fashion. We demonstrate that cross-linking of the inducible T-cell surface molecule CTLA4 can mediate apoptosis of previously activated human T lymphocytes. This function appears to be antigen-restricted, since a concomitant signal T-cell receptor signal is required. Regulation of this pathway may provide a novel therapeutic strategy to delete antigen-specific activated T cells.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Abatacept
-
Amino Acid Sequence
-
Antibodies, Monoclonal
-
Antigens, CD
-
Antigens, Differentiation / analysis
-
Antigens, Differentiation / immunology*
-
Antigens, Surface / immunology
-
Apoptosis / immunology*
-
CD28 Antigens / analysis
-
CTLA-4 Antigen
-
Cell Division
-
Cells, Cultured
-
Cross Reactions
-
Epitope Mapping
-
HLA-DR7 Antigen / immunology
-
Humans
-
Immunoconjugates*
-
Interleukin-2 / biosynthesis
-
Lymphocyte Activation
-
Molecular Sequence Data
-
Phytohemagglutinins / pharmacology
-
T-Lymphocytes / cytology*
-
T-Lymphocytes / drug effects
Substances
-
Antibodies, Monoclonal
-
Antigens, CD
-
Antigens, Differentiation
-
Antigens, Surface
-
CD28 Antigens
-
CTLA-4 Antigen
-
CTLA4 protein, human
-
HLA-DR7 Antigen
-
Immunoconjugates
-
Interleukin-2
-
Phytohemagglutinins
-
Abatacept